Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07516353 · ClinicalTrials.gov registry record · NA

my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults

A NA study, sponsored by Dana-Farber Cancer Institute.

Not yet
Registry status
NA
Development phase
143
Enrollment target

NCT07516353 is a NA study that has not yet begun recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 143 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07516353, a NA study, has not yet begun recruiting, sponsored by Dana-Farber Cancer Institute.

NOT YET RECRUITING
Registry status
NA
Development phase
143 participants
Enrollment target

Study Summary

This study aims to design and test a novel, personalized digital intervention-my.naviGATE-for adolescent and young adults (AYA) with cancer. my.naviGATE is a mobile app that provides personalized survivorship education, access to virtual peer navigation, and responsive participant-reported outcomes (PROs).

Interventions

  • BEHAVIORAL my.naviGATE Digital Tool

Trial Details

FieldValue
Enrollment Target 143 participants
Start Date 2026-08-20
Est. Completion 2030-12-31
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

What the Registry Record Tells You About NCT07516353

The ClinicalTrials.gov registry entry for NCT07516353 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which my.naviGATE Digital Tool is the first listed.

NCT07516353 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07516353 about?

NCT07516353 is a clinical study titled "my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults". This study aims to design and test a novel, personalized digital intervention-my.naviGATE-for adolescent and young adults (AYA) with cancer. my.naviGATE is a mobile app that provides personalized survivorship education, access to virtual peer navigation, and responsive participant-reported outcomes ...

What is the current status of trial NCT07516353?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 143 participants. The study started on 2026-08-20. Estimated completion is 2030-12-31.

What interventions are being tested in trial NCT07516353?

The interventions under investigation include: my.naviGATE Digital Tool (BEHAVIORAL).

Who is sponsoring clinical trial NCT07516353?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.